cCAM Biotherapeutics Closes Series A

cCAM Biotherapeutics, a company developing drugs to treat cancer, has closed on an undisclosed amount of Series A financing. The round was led by Arkin Holdings and included participation from OrbiMed's Israel Partners, Pontifax and F.Hoffmann La Roche, the company said. cCAM Biotherapeutics is based in Israel.

North AmericaUSBriefs